Australia sues 3M for $2B over PFAS cover-up
Australia sued manufacturing giant 3M (NYSE:MMM) for over $2 billion, alleging a decades-long cover-up of toxic "forever chemical" contamination.
Australia sued manufacturing giant 3M (NYSE:MMM) for over $2 billion, alleging a decades-long cover-up of toxic "forever chemical" contamination.
Imugene (ASX:IMU) announced a milestone in its ongoing Phase 1b basket study of azer-cel.
The Australian Prudential Regulation Authority has maintained its current macroprudential policy settings, citing a highly uncertain and volatile economic environment.
ReadCloud (ASX:RCL) core school-facing operations are currently on track to exceed their FY26 underlying EBITDA target of over $1 million.
HealthCo REIT (ASX:HCW) surrenders Healthscope’s Mount Private Hospital lease to Bethesda Health Care.
Champion Iron (ASX:CIA) logged a quarterly output, achieving 3.4 million wet metric tonnes produced and 3.5 million dry metric tonnes sold.
Shamaila Khan, UBS Asset Management Head of Global EM and APAC Fixed Income, speaks with Bloomberg TV about the strong opportunities in dollar-denominated emerging market assets.
Australia’s first eight-hour battery energy storage system entered full commercial operationin New South Wales.
Tetratherix (ASX:TTX) secured $15 million in firm commitments from prominent institutional investors via a two-tranche share placement.
A surge in data centre infrastructure has propelled Australian private new capital expenditure up by 6.5% in the March quarter.
Australian household spending fell by 1.1% in April, driven primarily by a sharp decline in transport costs.
AnteoTech (ASX:ADO) enters Japan's multi-billion dollar healthcare market, appointing Cosmo Bio as its primary distributor to scale its life sciences portfolio.